PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $38,000 | -88.3% | 12,966 | -88.8% | 0.00% | – |
| Q1 2020 | $326,000 | -3.6% | 115,786 | +11.1% | 0.00% | – |
| Q4 2019 | $338,000 | +61.0% | 104,189 | +6.9% | 0.00% | – |
| Q3 2019 | $210,000 | -16.0% | 97,444 | +22.4% | 0.00% | – |
| Q2 2019 | $250,000 | -23.8% | 79,603 | -9.8% | 0.00% | – |
| Q1 2019 | $328,000 | +23.3% | 88,215 | -3.8% | 0.00% | – |
| Q4 2018 | $266,000 | +59.3% | 91,652 | +45.0% | 0.00% | – |
| Q3 2018 | $167,000 | +12.8% | 63,218 | +0.0% | 0.00% | – |
| Q2 2018 | $148,000 | -32.7% | 63,196 | -15.3% | 0.00% | – |
| Q1 2018 | $220,000 | +14.0% | 74,571 | +5.9% | 0.00% | – |
| Q4 2017 | $193,000 | -44.5% | 70,425 | -31.3% | 0.00% | – |
| Q3 2017 | $348,000 | +31.8% | 102,528 | -4.0% | 0.00% | – |
| Q2 2017 | $264,000 | +106.2% | 106,800 | +89.4% | 0.00% | – |
| Q1 2017 | $128,000 | +0.8% | 56,380 | -5.9% | 0.00% | – |
| Q4 2016 | $127,000 | -11.2% | 59,914 | +40.8% | 0.00% | – |
| Q3 2016 | $143,000 | +60.7% | 42,558 | +50.4% | 0.00% | – |
| Q2 2016 | $89,000 | -9.2% | 28,302 | -4.0% | 0.00% | – |
| Q1 2016 | $98,000 | -3.9% | 29,478 | +1.8% | 0.00% | – |
| Q4 2015 | $102,000 | -28.2% | 28,945 | +2.2% | 0.00% | – |
| Q3 2015 | $142,000 | -21.5% | 28,320 | +0.8% | 0.00% | – |
| Q2 2015 | $181,000 | -12.1% | 28,109 | -4.0% | 0.00% | – |
| Q1 2015 | $206,000 | -83.4% | 29,281 | -81.8% | 0.00% | -100.0% |
| Q4 2014 | $1,240,000 | -48.9% | 160,779 | -50.5% | 0.00% | -50.0% |
| Q3 2014 | $2,427,000 | -2.2% | 324,829 | +26.7% | 0.00% | 0.0% |
| Q2 2014 | $2,481,000 | +12.1% | 256,282 | -3.8% | 0.00% | 0.0% |
| Q1 2014 | $2,213,000 | -1.7% | 266,312 | -0.2% | 0.00% | 0.0% |
| Q4 2013 | $2,252,000 | -73.1% | 266,727 | -74.7% | 0.00% | -76.5% |
| Q3 2013 | $8,386,000 | +55.1% | 1,052,215 | +50.2% | 0.02% | +41.7% |
| Q2 2013 | $5,407,000 | – | 700,426 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |